To include your compound in the COVID-19 Resource Center, submit it here.

Boehringer, Prime Therapeutics agree to outcomes-based contract for Jardiance

Boehringer Ingelheim GmbH (Ingelheim, Germany) entered into an

Read the full 83 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE